期刊簡介 | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | CANCER CYTOPATHOLOGY LetPub Score 7.4
50 ratings
Rate
Reputation 8.7 Influence 6.1 Speed 8.8 | ||||||||||||||||||||
期刊簡稱 | CANCER CYTOPATHOL | ||||||||||||||||||||
ISSN | 1934-662X | ||||||||||||||||||||
E-ISSN | 1934-6638 | ||||||||||||||||||||
h-index | 45 | ||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||
自引率 (2023-2024) | 15.40%自引率趨勢 | ||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||
官方網站 | http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1934-6638 | ||||||||||||||||||||
在線稿件提交 | https://mc.manuscriptcentral.com/cancercyto | ||||||||||||||||||||
開放訪問 | No | ||||||||||||||||||||
出版商 | Wiley-Blackwell | ||||||||||||||||||||
主題領域 | 医学 | ||||||||||||||||||||
出版國/地區 | UNITED STATES | ||||||||||||||||||||
發行頻率 | 隔月刊行 | ||||||||||||||||||||
創刊年 | 0 | ||||||||||||||||||||
每年文章數 | 66每年文章數趨勢 | ||||||||||||||||||||
黃金OA百分比 | 18.39% | ||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q2
| ||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Science Citation Index Expanded | ||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1934-662X%5BISSN%5D | ||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: Average 1 Month(s) | ||||||||||||||||||||
競爭力 * | 來自作者的數據: About 25% | ||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 下一頁 末頁 (頁 | |
[CANCER CYTOPATHOLOGY] 的評論 | 撰寫評論 |
作者: 白夏少爷 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-11-17 16:13:03 評論於 Have you voted? Planning to give it a try?(0) 讚! | 白夏少爷 |
作者: 东风从青 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-08-14 23:37:35 評論於 Are you accepting articles on research into basic class mechanism functionality?(0) 讚! | 东风从青 |
作者: 东风从青 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-08-14 22:53:59 評論於 Are you accepting articles on the study of basic mechanisms of class acceptance?(0) 讚! | 东风从青 |
作者: 东风从青 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-08-13 16:45:49 評論於 Are there any recent recipients? Is it good? Please share your experience, grateful heart!(0) 讚! | 东风从青 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 22:26:24 評論於 Thank you to the editors and reviewers; revisions take time, but experiments require time; please confirm the time needed(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 10:09:00 評論於 Subject: Submission column, article title, pen name for publication. Content: The entire content of the article. Author information is at the end of the text. Author information includes: your actual contact address, zip code, name, email address, landline phone, mobile phone, QQ number (specify QQ name), and any other contact information you feel is necessary to provide (such as a brief introduction(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 魂魄彦露 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-27 14:41:08 評論於 What are some things to keep in mind when sending a letter to a journal?(0) 讚! | 魂魄彦露 |
作者: 陶宜三岁啦 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-27 12:39:37 評論於 How to write a letter requesting an extension?(0) 讚! | 陶宜三岁啦 |
作者: 无冬嘉歆 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-07-21 08:03:47 評論於 Review speed: 1.0 | Submission hit rate: 50.0 Emphasized research direction: Oncology Metabolic experience sharing: After submitting the review, I received a rejection letter just 3 hours later, because they felt that the content of the submission did not quite align with their audience. They recommended submitting to another OA journal from the same publisher with a fee of 3.49. I agreed, but I am unsure of what will happen next. I will provide an update if it gets accepted(0) 讚! | 无冬嘉歆 |
作者: 千花婉淑 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-05-05 17:15:07 評論於 This magazine has such high circulation, why was it canceled?(0) 讚! | 千花婉淑 |
作者: Barbee 領域: 医学 審稿時間: 4.0 month(s) 結果: 待定&不明 撰寫評論 |
2019-01-21 17:00:51 評論於 Overall, Cancer Cytopathology is a very good journal. I wish that the review period was a little faster, and I hope that more articles are submitted so that it starts publishing monthly. (0) 讚! | Barbee |
作者: Marshall Arnold 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2019-01-20 20:35:11 評論於 Overall, it is a very good journal. I just hope the review process can be faster, and it would be great if it could become a monthly publication(0) 讚! | Marshall Arnold |
作者: 云居吉敏 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-10-15 19:47:06 評論於 I'd like to ask, is nobody submitting to this magazine? Could you please provide some feedback? I'm thinking of submitting, but it seems like there are few submissions from China(0) 讚! | 云居吉敏 |
作者: Jonas Franklin 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-08-31 17:33:25 評論於 Submission rejection is really quick. I regret to inform you that the manuscript was not deemed to be within the top 20% of submitted manuscripts, and has not been accepted for publication in Cancer Cytopathology(0) 讚! | Jonas Franklin |
作者: 水月语芹 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2015-11-05 15:52:56 評論於 How much is the advertising fee?(0) 讚! | 水月语芹 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2015-05-01 13:49:59 評論於 It seems not, it should be a subsidiary publication(0) 讚! | 凌霄高洁 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2014-09-25 23:30:09 評論於 The submission is on the neuropathology of cerebrospinal fluid cells. The initial review is slow, taking about 3-4 months. After revision, there are 3 reviewers, the first 2 did not raise any issues. The third reviewer's comments are very strict, suggesting additional research that cannot be completed in a short period of time. The revision took 3 months (with a 1.5-month extension), followed by nearly 2 months for another review, and ultimately, the submission was rejected. There are many minor issues with the language of the article and the clarity of the images, but these are problems that can be resolved. It is difficult to accept that after about 8 months of review, the submission is rejected after one major revision. Subsequently, the score for this journal dropped drastically this year(0) 讚! | 凌霄高洁 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2014-07-03 22:46:14 評論於 Are Cancer and Cancer Cytopathology the same journal?(0) 讚! | 凌霄高洁 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2013-05-15 23:20:20 評論於 What does "ON COPYEDIT" mean and what status should it be in?(0) 讚! | 凌霄高洁 |
作者: 凤凰院俏丽 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2012-11-20 12:56:01 評論於 Review speed: 1.0 | Submission acceptance rate: 25.0 Sharing experience: It's really refreshing. Rejected in three days is better than lingering rejection. No reasons given. It's a good journal, saves time(0) 讚! | 凤凰院俏丽 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2012-06-23 18:15:24 評論於 Rejected in just 3 days, it feels really difficult(0) 讚! | 凌霄高洁 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2012-01-06 19:20:59 評論於 The journal name here is wrong, it should be abbreviated as CANCER-AM CANCER SOC, not cancer cytopathologyJ abbreviation, they are not the same journal at all. Change it quickly!(0) 讚! | 凌霄高洁 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2011-03-10 10:21:56 評論於 Review Speed: 2.0 Experience Sharing: A good magazine, but not very popular domestically(0) 讚! | 凌霄高洁 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2011-02-08 22:10:18 評論於 The review process takes approximately 4-6 weeks for the first round, not 2-3 weeks(0) 讚! | 凌霄高洁 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2011-01-26 10:29:24 評論於 Rejected in three days. Editing is very good, at least it can save time(0) 讚! | 凌霄高洁 |
首頁 上一頁 1 下一頁 末頁 (頁 |
Contact us